The findings will help push clinicians closer to personalized medicine for lupus sufferers.
The discovery could lead to new therapeutic approaches to a wide range of illnesses, including asthma, inflammatory bowel disease and psoriasis.
New research from OMRF is taking physicians closer to personalized treatment solutions for patients suffering from lupus.
The grant will provide Bob Axtell with $2.8 million to study NMO and investigate its similarities to other autoimmune diseases, particularly MS.
Alberola-Ila will investigate the role a type of white blood cell plays in mounting the body’s response against flu infection.
Lupu’s findings were published in the Proceedings of the National Academy of Sciences.